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Enhanced enzymatic activity from phosphotriesterase trimer gold
nanoparticle bioconjugates for pesticide detection
Abstract
The rapid detection of organophosphates (OPs), a class of strong neurotoxins, is critically important for
monitoring acute insecticide exposure and potential chemical warfare agent use. Herein, we improve the
enzymatic activity of a phosphotriesterase trimer (PTE3), an enzyme that selectively recognizes OPs directly,
by conjugation with distinctly sized (i.e., 5, 10, and 20 nm diameter) gold nanoparticles (AuNPs). The
number of enzymes immobilized on the AuNP was controlled by conjugating increasing molar ratios of PTE3
onto the AuNP surface via metal affinity coordination. This occurs between the PTE3-His6 termini and the
AuNP-displayed Ni2+-nitrilotriacetic acid end groups and was confirmed with gel electrophoresis. The
enzymatic efficiency of the resultant PTE3–AuNP bioconjugates was analyzed via enzyme progress curves
acquired from two distinct assay formats that compared free unbound PTE3 with the following PTE3–AuNP
bioconjugates: (1) fixed concentration of AuNPs while increasing the bioconjugate molar ratio of PTE3
displayed around the AuNP and (2) fixed concentration of PTE3 while increasing the bioconjugate molar
ratio of PTE3–AuNP by decreasing the AuNP concentration. Both assay formats monitored the absorbance
of p-nitrophenol that was produced as PTE3 hydrolyzed the substrate paraoxon, a commercial insecticide and
OP nerve agent simulant. Results demonstrate a general equivalent trend between the two formats. For all
experiments, a maximum enzymatic velocity (Vmax) increased by 17-fold over free enzyme for the lowest
PTE3–AuNP ratio and the largest AuNP (i.e., ratio of 1[thin space (1/6-em)]:[thin space (1/6-em)]1, 20 nm
dia. AuNP). This work provides a route to improve enzymatic OP detection strategies with enzyme–NP
bioconjugates.
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Enhanced enzymatic activity from
phosphotriesterase trimer gold nanoparticle
bioconjugates for pesticide detection†
John A. Hondred, a Joyce C. Breger,b Nate T. Garland,a Eunkeu Oh, c,d
Kimihiro Susumu,c,d Scott A. Walper,b Igor L. Medintz b and
Jonathan C. Claussen *a
The rapid detection of organophosphates (OPs), a class of strong neurotoxins, is critically important for
monitoring acute insecticide exposure and potential chemical warfare agent use. Herein, we improve the
enzymatic activity of a phosphotriesterase trimer (PTE3), an enzyme that selectively recognizes OPs
directly, by conjugation with distinctly sized (i.e., 5, 10, and 20 nm diameter) gold nanoparticles (AuNPs).
The number of enzymes immobilized on the AuNP was controlled by conjugating increasing molar ratios
of PTE3 onto the AuNP surface via metal aﬃnity coordination. This occurs between the PTE3-His6 termini
and the AuNP-displayed Ni2+-nitrilotriacetic acid end groups and was conﬁrmed with gel electrophoresis.
The enzymatic eﬃciency of the resultant PTE3–AuNP bioconjugates was analyzed via enzyme progress
curves acquired from two distinct assay formats that compared free unbound PTE3 with the following
PTE3–AuNP bioconjugates: (1) ﬁxed concentration of AuNPs while increasing the bioconjugate molar
ratio of PTE3 displayed around the AuNP and (2) ﬁxed concentration of PTE3 while increasing the bio-
conjugate molar ratio of PTE3–AuNP by decreasing the AuNP concentration. Both assay formats
monitored the absorbance of p-nitrophenol that was produced as PTE3 hydrolyzed the substrate para-
oxon, a commercial insecticide and OP nerve agent simulant. Results demonstrate a general equivalent
trend between the two formats. For all experiments, a maximum enzymatic velocity (Vmax) increased by
17-fold over free enzyme for the lowest PTE3–AuNP ratio and the largest AuNP (i.e., ratio of 1 : 1, 20 nm
dia. AuNP). This work provides a route to improve enzymatic OP detection strategies with enzyme–NP
bioconjugates.
Introduction
Organophosphates (OPs) are widely used as neuroinhibitory
pesticides to prevent crop loss.1 However, OPs pose a signifi-
cant risk to the environment through water run-oﬀ and an
even greater risk to humans in the form of nerve agents that
are used in chemical weapons (e.g., Soman and Sarin).2 OPs
released into the environment degrade with time, but such
degradation has not prevented trace levels appearing in drink-
ing water supplies.3 Therefore, there is a strong need to
produce sensors that can rapidly assess and continuously
monitor exposure/contamination from OP-based pesticides
and chemical warfare/terror agents before such chemicals
have the opportunity to leech deep into the soil. Enzyme-
based biosensors display tremendous promise for rapid,
continuous, and low-cost biosensing needed for in-field OP
sensing.4–8
Several enzymes have been explored for enzymatic OP
sensing including organophosphate hydrolase (OPH).9 OPH is
a lipoprotein that hydrolyzes the triester bond of OP pesti-
cides10 such as paraoxon, methyl-parathion and diazinon11
and has been shown to hydrolyze paraoxon rapidly – paraoxon
breakdown by OPH appears to approach the diﬀusion limit of
the substrate (V/KM ≈ 108–109 M−1 s−1).12 Phosphotriesterase
from Brevundimonas diminuta is an OPH variant of specific
interest as it is able to selectively target triple O-linked phos-
phonate centers such as those found in Sarin and Tabun.13
Multiple derivative OPH structures, including a de novo
†Electronic supplementary information (ESI) available. See DOI: 10.1039/
c6an02575g
aDepartment of Mechanical Engineering, Iowa State University, United States Ames,
IA 50011, USA. E-mail: jcclauss@iastate.edu
bCenter for Bio/Molecular Science and Engineering, Code 6900, U. S. Naval Research
Laboratory, Washington, DC 20375, USA
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chimeric collagen-PTE trimer (PTE3), have been engineered to
increase the enzyme’s activity within specific and targeted
applications.14 However, the reaction kinetics and stability of
OPH and some of its derivatives are currently not considered
suﬃciently robust nor suﬃciently sensitive for use in portable,
field-deployable OP biosensing devices.
For decades, researchers have been exploring possible solu-
tions for increasing the stability and activity of OPH with
diverse immobilization techniques. For example, protein
fusion, which anchors OPH onto the surface of Escherichia coli
using an Lpp-OmpA fusion protein, demonstrated a seven-
fold increase in parathion degradation.15 OPH entrapment
within a polyurethane foam matrix provided increased enzy-
matic life (1.8 days soluble and 278 days immobilized when
stored at 25 °C) and thermal stability (1.5 hours soluble and
158.4 hours immobilized at 50 °C).16 Researchers have also
demonstrated that OPH retained enhanced enzymatic stability
when attached to nanomaterials such as silica matrices (no
significant loss after 12 months),17 amyloid fibrils (300%
increase in relative temperature stability at 40, 45, and
50 °C),18 carbon nanotubes (only 25% signal loss after
7 months),19 and nanoparticles (NPs) such as nanocrystalline
semiconductor quantum dots (QDs).20 The latter provide bio-
compatible surfaces, potential for enhanced conductivity
through direct enzyme electrical ‘wiring’,21 and high surface
area for immobilization of enzymes. In this vein, we recently
demonstrated that PTE3 has enhanced activity when displayed
on CdSe/ZnS core/shell QDs.20 Indeed, recent research has
shown that enzyme immobilization on NPs in general can
increase both the sensitivity and stability of enzymes for a
variety of applications.22–24
While the exact interaction and catalytic nature between
NPs and enzymes are complex and much is still unknown, the
specific characteristics of enzyme–NP conjugates such as mass
transport, enzyme orientation, surface morphology, and
enzyme density have been shown in many cases to enhance
enzymatic performance.24–26 NPs have unique properties of
high surface-to-volume ratios as well as high radii of curvature
which can potentially allow enzymes to be positioned with
increased distance between adjacent immobilized enzymes;
this may limit unfavorable protein to protein interaction(s) on
the NP surface.27 Enzyme–NP bioconjugates can be further
manipulated by changing the attachment chemistry of the
enzyme in order to situate the enzyme’s binding pocket away
from the NP while optimizing the position for substrate to
diﬀuse to and from the enzyme. Enzymes that have been
immobilized onto the surface of NPs display improvements in
activity along with a wider performance window across a range
of pH and temperature changes.28 These advantages have not
only provided enhanced enzyme activity, stability, and speci-
ficity, but have also improved the ability of enzymes to be used
in sensors for a variety of conditions such as for the highly sen-
sitive detection of glutamate, glucose, lactate in simulated or
actual biological solutions/conditions.28–33 Moreover, we have
shown that immobilizing the enzyme alkaline phosphatase
onto QDs can improve the enzymatic eﬃciency (kcat/KM) up to
40% versus free enzyme.23 We have also shown that immobiliz-
ing trypsin substrate onto NPs can enhance enzymatic activity
in Förster resonance energy transfer (FRET) assays where the
rate of trypsin-catalyzed proteolysis of QD-displayed peptide
increased to five times that of free enzyme.34 AuNPs have
shown enhanced eﬀects on a variety of small molecules such
as improved aﬃnity for Alzheimer’s peptide Aβ (a factor of
7 higher for NP-immobilized D3 than for the free ligands)35
and anti-viral lectin Cyanovirin-N (several orders of magnitude
higher than isolated monomeric sugars interacting with the
lectin),36 increased enzyme selectivity of α-chymotrypsin (∼3-
fold improvement for cationic substrates),37 and lowered KM
values of glucose oxidase (1.56-fold lower in magnitude
than free glucose oxidase);38 however, the enhanced enzymatic
performance of OPH using AuNP has not been researched.
Here, we improve the performance of PTE3 via immobilization
onto gold nanoparticles (AuNPs). PTE3 is attached to the AuNP
via metal-aﬃnity interactions allowing for ratiometric and
orientation control on the AuNP.39 This method orients
the catalytic site on the outside of the bioconjugate increasing
the likelihood of enzyme/substrate binding to occur.40
PTE3 was immobilized onto 5, 10, and 20 nm diameter AuNPs
in an eﬀort to analyze trends between enzyme activity and NP
carrier size/curvature along with immobilized enzyme density,
see Fig. 1. In this work, the organophosphate paraoxon was
used as substrate since its hydrolysis produces p-nitrophenol
which has a distinct, measurable absorbance (405 nm).14
PTE3–AuNP performance was monitored in two distinct
Fig. 1 Left: Schematic diagram of AuNP–PTE3 conjugate preparation.
AuNPs were surface functionalized with 50% dihydrolipoic acid (DHLA)
and 50% nitrilotriacetic acid appended dihydrolipoic acid (DHLA-NTA).
The NTA groups were preloaded with Ni2+ as described in the Methods.
PTE3 coordinates by metal aﬃnity to the Ni
2+-NTA displayed around the
AuNPs to yield the ﬁnal AuNP–PTE3 bioconjugate. Right: Hydrolysis of
paraoxon due to OPH catalyst into p-nitrophenol. Note, ﬁgure is not
drawn to scale.
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formats: fixed amounts of AuNPs where the molar ratio
of PTE3 per AuNP was systematically increased and fixed
concentrations of PTE3 where the amount of AuNPs were
systematically decreased to increase the ratio of PTE3/AuNP.
The data again confirms enzymatic enhancement of PTE3
when displayed on NP and that this can be extended to other
types of NP materials with diﬀerent sizes utilizing diﬀerent
enzyme attachment chemistries.
Experimental methods
Chemicals
Paraoxon was purchased from Chem Services (USA). All other
chemicals including solvents were purchased from Sigma-
Aldrich (USA) or Acros Organics (USA), unless indicated other-
wise, and used as received without any other further purifi-
cation unless stated. The use of these chemicals are outlined
in the following sections of this Experimental methods
section.
PTE3 expression
Briefly, the gene cassette encoding the phosphotriesterase
gene (PTE, EC 3.1.8.1) from Brevundimonas diminuta and the
collagen-like protein from Streptococcus pyogenes was syn-
thesized by Genescript. The multimerization domain consisted
of the V-domain which facilitates assembly of the structure
and a collagen helix comprised of 78 repeats of the glycine
trimer (Gly-Xaa-Yaa). The cassette was flanked by unique,
terminal restriction enzyme cleavage sites which facilitated
cloning into either the cytoplasmic or periplasmic pET
bacterial expression plasmids (Takara Bio, USA). Integration
into either expression construct allowed for the addition of a
C-terminal hexahistidine tag (His6) that is used for purification
of the protein with immobilized metal aﬃnity chromatography
(IMAC). Additional details on vector construction can be found
in our previous work.14
Expression of the PTE3 was performed in E. coli strain BL21
(DE3). Briefly, 500 mL of Terrific Broth containing the appro-
priate antibiotic was inoculated with 5 mL of an overnight
culture. The culture was maintained at 37 °C for 3 hours or
until mid-log phase was reached. Expression of the recombi-
nant protein was induced with isopropyl-β-D-1-thiogalactopyra-
noside (IPTG) at a final concentration of 0.25 mM. The culture
was maintained at 30 °C for 15–24 hours then centrifuged at
4000g to pellet the cells. The resultant cell pellet was frozen at
−80 °C for a minimum of 3 hours to aid in cell lysis. Following
the incubation at −80 °C, cells were resuspended in 30–50 mL
of lysis buﬀer (0.5× phosphate buﬀered saline – PBS, 69 mM
NaCl; 1.4 mM KCl, pH 7.4), 1 mM ethylenediamine tetraacetic
acid (EDTA), 0.1% Triton X-100, 2 mg mL−1 lysozyme and incu-
bated on ice for 30 minutes with constant, slow agitation. The
cell slurry was then sonicated 6 times at 30 seconds intervals
using a Branson Sonifier (constant output, duty cycle 5).
Soluble and insoluble material was separated via centrifu-
gation at 15 000g for 30 minutes. Soluble material was dec-
anted to a fresh conical tube and combined with Ni2+-nitrilo-
triacetic acid (Ni-NTA) resin (GE Healthcare). The insoluble
material was reserved for later analysis via sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Protein
was immobilized to the IMAC resin via batch mixing for
3 hours at 4 °C. Following this incubation, the resin was batch
washed with 30–40 bed volumes of wash buﬀer (20 mM phos-
phate pH 7.5, 150 mM NaCl, 25 mM imidazole). Protein was
eluted from the column using wash buﬀer with imidazole at a
final concentration of 200 mM. Formation of the triple helix
was not spontaneous. IMAC purified protein was incubated for
an additional 48–72 hours to allow for formation of the multi-
mer. Size exclusion chromatography was performed using an
Enrich SEC650 fast protein liquid chromatography (FPLC)
column and BioRad Biologic System to separate the triple helix
construct from the monomeric protein. Additional details
regarding these processes can be found in previous work.14,23
Gold NP synthesis and preparation
Citrate-modified AuNPs were first synthesized using a slightly
modified citrate reduction protocol and the final NTA-
modified AuNPs were obtained using a second ligand
exchange method as described elsewhere.41,42 For the AuNP
synthesis, 100 mM of HAuCl4·3H2O stock solution and
200 mM of trisodium citrate (Na3C6H5O7) were prepared in de-
ionized water. Next, 100 µL of stock HAuCl4·3H2O was added
to 50 mL of water and vigorously stirred for 1 min followed by
the addition of 200 μL or 50 μL citrate stock solution for the
creation of the 5 nm and 10 nm AuNPs, respectively. After
5 min of stirring, 100 μL of 100 mM NaBH4, freshly prepared
in water, was added to the reaction solution and stirred for an
additional 20 min for the reduction and formation of gold col-
loids. The 20 nm citrate-modified AuNPs were prepared in
50 μL of citrate stock solution in a similar manner except the
solution was boiled for 30 min without NaBH4.
For preparing NTA-modified AuNPs, 10 mL of as-syn-
thesized citrate-modified AuNPs were mixed with excess
amount of mixed ligand stock solution (100, 50, 25 µL of
100 mM stock for the 5, 10, 20 nm AuNPs, respectively) con-
taining 50% of dihydrolipoic acid (DHLA) and 50% NTA-
appended dihydrolipoic acid (DHLA-NTA) which had been
deprotected with an equivalent molar concentration of NaOH for
an hour before being mixed with DHLA and the solution was
stirred for 4 hours. DHLA-NTA was prepared as described.43 The
final NTA-modified AuNPs were washed with water three times
and purified using centrifugation with a centrifugal membrane
filter (Millipore, 50–100 K molecular weight cut-oﬀ membrane
filter) to remove free unbound ligands. High resolution trans-
mission electron microscopy (TEM) images were taken to
confirm both the size and standard deviation of the AuNPs with
a sample size of approximately n = 100 for each distinct AuNP
size (5, 10, and 20 nm).
AuNPs were loaded with Ni2+ for metal aﬃnity coordination
driven binding to the PTE3’s terminal His6 motifs using a
cation exchange column procedure. Briefly, the cation
exchange column (10 cm length × 1 cm diameter) was pre-
Analyst Paper
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pared using CM Ion Exchange Chromatography Resin (Biorad)
and saturated with a 0.1 M NiCl2 stock solution in water. The
as-prepared NTA-modified AuNPs were added to the top of CM
column and kept in the column for at least 30 min to promote
the interaction between the Ni2+ and NTA on the surface of the
AuNP. The Ni2+-NTA-modified AuNPs were eluted from the
column using deionized water. The eluent solution was con-
centrated using a centrifugal membrane filter. For preparing
PTE3–AuNP, 25 µL PTE3 of various molarities was allowed to
self-assemble overnight with 25 µL of 5, 10, and 20 nm Ni2+-
NTA-modified AuNPs to complete the binding of the
PTE3 enzyme’s His6-tag to the Ni
2+-NTA as schematically
demonstrated in Fig. 1. The enzyme to NP ratios were created
by mixing the following molar concentrations for the 5, 10,
and 20 nm sized AuNPs. For the 5 nm AuNPs, 3 picomoles
of AuNPs were mixed with 0 to 54 picomoles of PTE3 to
achieve PTE3–AuNP ratios of 0 to 18 respectively while the final
concentration of AuNPs in each sample was 120 nM. For the
10 nm AuNPs, 0.5 picomoles of AuNP were mixed with 0 to
5 picomoles of PTE3 to achieve PTE3–AuNP ratios of 0 to
10 PTE while the concentration of AuNP in each sample was
25 nM. For the 20 nm AuNPs, 0.25 picomoles of AuNPs were
mixed with 0 to 2.5 picomoles of PTE3 to achieve PTE3–AuNP
ratios of 0 to 10 while the final concentration of AuNPs in each
sample was 5 nM.
Transmission electron microscopy
Structural characterization of as-prepared NPs was carried out
using a JEOL 2200-FX analytical high-resolution transmission
electron microscope (TEM) with a 200 kV accelerating voltage.
Samples for TEM were prepared by spreading a drop (5–10 µl)
of the filtered NPs dispersion (filtered using 0.25 µm Millipore
syringe filters) onto ultrathin carbon/holey support film on a
300 mesh Au grid (Ted Pella, Inc.) and letting it dry. The con-
centration of NPs in the deionized water used was typically
∼1–10 nM. Individual particle sizes were measured using a
Gatan Digital Micrograph (Pleasanton, CA); average AuNP dia-
meters and their corresponding standard deviations were
extracted from measuring the size of ∼100 NPs from each
sample size.
Dynamic light scattering
Dynamic light scattering (DLS) measurements were carried out
using ZetaSizer NanoSeries equipped with a HeNe laser source
(λ = 633 nm) (Malvern Instruments Ltd, Worcestershire, UK)
and analyzed using Dispersion Technology Software (DTS,
Malvern Instruments Ltd, Worcestershire, UK). 10 nM concen-
tration solutions of AuNPs, PTE3-conjugated AuNPs or equi-
valent amount of PTE3 were loaded into disposable cells and
data were collected at 25 °C. All the samples were prepared in
0.1× PBS buﬀer, pH 7.4. For each sample, the autocorrelation
function was the average of five runs of 10 seconds each and
repeated between three to six times. CONTIN analysis was then
used to quantify the hydrodynamic size profiles for the disper-
sions studied.
Zeta-potential
For zeta-potential (ζ-potential) measurement, Laser Doppler
Velocimetry (LDV) measurements were performed using a
ZetaSizer NanoSeries equipped with a HeNe laser source (λ =
633 nm) (Malvern Instruments Ltd, Worcestershire, UK) and
an avalanche photodiode for detection, controlled with DTS
software. 10 nM concentration solutions of AuNPs, PTE3-conju-
gated AuNPs or equivalent amount of PTE3 were loaded into
disposable cells and data were collected at 25 °C. Three runs
of the measurements were performed for each sample to
achieve the zeta potential. All the samples were prepared in
0.1× PBS buﬀer pH 7.4.
Confirmation of PTE3–AuNP self-assembly
AuNP–PTE3 bioconjugates were confirmed by separation using
agarose gel electrophoresis. AuNP–PTE3 conjugates were
loaded into wells of a 1% low electroendosmosis agarose gel
supplemented with 1× TBE buﬀer (89 mM Tris-borate and
2 mM EDTA, pH 8.3). A potential of 95 volts was then applied
and the negatively-charged AuNP–PTE3 conjugates were
allowed to diﬀuse towards the cathode. Images were taken ca.
every 5 min on a Bio-Rad ChemiDoc Molecular Imager to visu-
ally monitor the diﬀerential changes in AuNP conjugate elec-
trophoretic mobility in response to bioconjugation ratio.
Enzyme assays
The insecticide paraoxon was used as a model OP substrate for
the PTE3 assays. PTE3 hydrolyzes the phenol groups yielding a
p-nitrophenol product which has a characteristic absorption
centered at 405 nm (molecular extinction coeﬃcient of
∼18 000 M−1 cm−1). Experimentally, varying molar ratios of
PTE3 were functionalized to the 5, 10, and 20 nm AuNPs. Two
experimental formats were utilized. Fixed amounts of AuNPs
where the molar ratio of PTE3 per AuNP was systematically
increased and fixed concentrations of PTE3 where the amount
of AuNPs was systematically decreased to increase the ratio of
PTE3/AuNP. Bioconjugate activity was assayed and compared
to free PTE3 using a similar method as previously described.
44
It should be noted that the AuNP–PTE3 ratios chosen were far
below surface saturation in most cases to ensure that all
enzymes were attached to the AuNPs. Conjugates and enzyme
only controls were diluted into a final concentration series of
paraoxon ranging from 20 to 5000 µM within 384-well Corning
flat bottom, non-binding microtiter plates.45 Assays were
carried out in a Tecan Infinite M1000 dual monochromator
multifunctional plate reader using a xenon flash lamp (Tecan,
Research Triangle Park, NC) to measure the absorbance at
405 nm every 20 seconds. The absorbance values were con-
verted to p-nitrophenol concentrations via a standard cali-
bration curve of p-nitrophenol ranging from 0 to 200 µM.46
While there is a small overlap in extinction spectrum of col-
loidal AuNP and p-nitrophenol, the contributions of AuNP
accounts for less than 0.1% of the total optical density due to
the small concentration used (i.e., optical density originating
from the 5, 10, and 20 nm AuNPs amounted to 0.002%,
Paper Analyst
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0.013%, and 0.07% respectively as compared to the total
optical density of each solution via UV-Vis spectrophotometer
measurements). Therefore, the extinction spectrum of col-
loidal AuNPs is negligible as compared to the extinction spec-
trum of p-nitrophenol. All assays were performed twice and
average values utilized with standard deviations where appro-
priate. Initial rates of PTE3 activity and kinetic parameters
were determined using the enzyme kinetics module within the
SigmaPlot software which uses a non-linear curve fit for a
single substrate.
Results and discussion
PTE3–AuNP synthesis and assembly
We have previously reported the enhancement of PTE and the
PTE3 trimer when attached to Cd-containing semiconductor
QDs14,20 and in this work the PTE3 trimer is attached to a non-
toxic, Cd-free AuNP. The PTE3 trimer was prepared by append-
ing the PTE gene to a collagen-derived triple helix domain and
a trimerizing V domain followed by a terminal His6 motif as
described in the Methods. The PTE-collagen-His6 monomer
has an estimated Mw of ∼53 kDa while the fully assembled
PTE3 trimer has an estimated Mw of ∼155 kDa. The PTE3
trimer was immobilized onto AuNPs of distinct diameter (i.e.,
5 nm, 10 nm, and 20 nm) which were synthesized as described
in the Methods. The native citrate stabilizing ligand was cap
exchanged with a mixture of 50 : 50 DHLA and DHLA-NTA
which provides the AuNPs with both aqueous colloidal stability
across a broad pH and ionic range and the ability to spon-
taneously coordinate the PTE3 protein via metal aﬃnity coordi-
nation following charging of the NTA group with Ni2+ (see
Fig. 1).47 This is, for all intents and purposes, the same inter-
action and mechanism by which the proteins were originally
purified using commercial IMAC media. This approach allows
for ratiometric control over the number of PTE3 assembled to
each AuNP simply by varying the molar amounts of each
mixed together. It also allows for orientational control, i.e. dis-
playing the active site away from the NP surface, a factor that is
important for minimizing the conjugate’s structural hetero-
geneity which can, in turn, detrimentally decrease enzyme
activity.48 The PTE-His6 motif, attached to the C-terminal of
each of the three monomers, allows for the enzymatic binding
pocket to orientate itself on the outward side of the enzyme–
NP bioconjugate. Although each PTE3 construct will ultimately
display 3 × His6 on their termini due to its trimeric nature,
functional results show no evidence of crosslinking between
the AuNPs, but rather excellent conjugate stability presumably
due to the cumulative-synergistic nature of the multiple inter-
actions at the NP interface.
AuNP and PTE3–AuNP bioconjugate characterization
To confirm the size of the as-synthesized AuNPs, high resolu-
tion TEM images were collected from each sample batch
(Fig. 2, left). As confirmed in the representative TEM micro-
graphs shown in Fig. 2, the sample sizes (n ∼ 100) corre-
sponded to 5 ± 0.9 nm, 10 ± 1.4 nm and 20 ± 3.0 nm diameter
AuNPs. This, in turn, corresponds to approximate surface
areas of ∼79 nm2, ∼314 nm2, and ∼1257 nm2 along with esti-
mated curvatures of ∼0.4 nm−1, ∼0.2 nm−1, and ∼0.05 nm−1,
respectively. Structural modeling, similar to that described pre-
viously,14,23 was used to estimate maximum enzyme packing
densities of ca. 30, 50, and 120 PTE3 that should fit onto the 5,
10, and 20 nm AuNPs. These large packing numbers result
from the elongated PTE3 structure which places the large glob-
ular enzymes quite distal from the tight constraints of the NP
surface where only the far smaller His6 motifs bind. This also
assumes no steric hindrance between neighboring proteins
and that the NTA binding moiety is equally displayed around
the AuNPs in suﬃcient numbers to facilitate such a dense
binding.49
Agarose gel electrophoresis was next conducted to confirm
PTE3 physically assembled to the AuNPs with ratiometric
display (Fig. 2, right). Incrementally increasing ratios of PTE3/
AuNP were assembled to the NPs overnight as described in the
Methods and loaded into 1% agarose gels for electrophoretic
separation. The gels were visualized at 5 minutes intervals on
a lightbox to monitor the eﬀects of PTE3–AuNP conjugation on
Fig. 2 Left: Representative high resolution transmission electron microscopy (TEM) micrographs of the 5, 10, and 20 nm AuNPs. Right: Agarose gel
electrophoresis analysis of three diﬀerent-sized AuNPs assembled with varying ratios of PTE3 as indicated at the top. Images were collected every
5 min during separation.
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migration properties. As shown in Fig. 2, the unbound AuNPs
migrate fastest towards the anode due to the high net negative
charge from the DHLA and DHLA-NTA carboxyl endgroups.
As the ratio of assembled PTE3–AuNP increases, the resulting
migration of the complexes decreases in a manner that is
directly proportional to the enzyme–AuNP ratio. This is a
direct result of the increase in mass and hydrodynamic size
along with changes to the overall net charge of the complex.
The latter are quite complex to predict due to the diﬀerent
sizes and surface areas involved. The smaller 5 nm AuNPs dis-
played the largest change in migration as expected since their
size is closest to that of the enzyme. Overall, this confirms that
the PTE3 does assemble to these NPs with suﬃcient aﬃnity to
maintain the structure while being driven through a sieving
matrix. Moreover, the assembly occurs in a direct ratiometric
manner.
DLS and zeta potential were also utilized to monitor the
increase in hydrodynamic diameter (HD) of the AuNP as a
function of the increase in attached PTE3. The hydrodynamic
size and the zeta potential of the AuNPs were changed after
conjugation of PTE3, which confirmed that the conjugation
was achieved after 2 hours of incubation. A HD of 10.1 ±
0.65 nm, 17.1 ± 1.7 nm, and 50.5 ± 1.93 nm was measured
for the initial 10 nm AuNP before functionalization, after
DHLA/DHLA-NTA functionalization, and after conjugation
with PTE3 in a molar concentration ratio of 32 : 1 with the
AuNPs, respectively. The measured hydrodynamic size of the
PTE3-conjugated AuNP was slightly larger than expected,
which perhaps is due to the mild aggregation in the solution
caused by excess amount of unbound PTE3. The zeta-potential
value of the 10 nm AuNP for the same scenario decreased
from −9.8 ± 1.72 for the AuNP (10 nm) before functionalization
and to −28.7 ± 1.14, and −12.0 ± 1.5 mV after functionalization
with DHLA/DHLA-NTA and PTE3 (32 : 1 PTE3 to AuNPs)
respectively which suggests that the negatively charged surface
of the AuNP becomes more charged with the DHLA/DHLA-NTA
functionalization but less so with enzyme conjugation. The
inclusion of the enzyme increased the hydrodynamic drag
(∼17 nm to ∼50 nm) which may have reduced the mobility of
the particle in the electrophoretic field neutralizing, to some
degree, the zeta potential.
PTE3–AuNP activity characterization via fixed AuNP concen-
tration method
Full enzyme progress curves were first acquired by fixing the
concentration of AuNPs while increasing the bioconjugate
molar ratio of PTE3 displayed around the AuNP. This “fixed
AuNP concentration method” was carried out with 5, 10, and
20 nm AuNP scaﬀolds at 0.5 pM (which corresponds to a gold
mass concentration of 0.0008%, 0.006%, and 0.05%, respect-
ively)50 while the PTE3 concentration was varied to yield dis-
tinct AuNP–PTE3 ratios (Fig. 3). The kinetic activity of the said
PTE3–AuNP bioconjugates was tested and compared to an
equivalent amount of control free PTE3. The resulting changes
in absorbance from these experiments (see ESI Fig. 1S and
2S†) were converted into product concentration by linear
interpolation to a p-nitrophenol calibration curve
(Experimental methods). The initial rate of paraoxon hydro-
lysis for each of the PTE3–AuNP conjugates and corresponding
controls of free enzyme were then plotted against the substrate
concentration and fitted with the Michaelis–Menten equation,
see Fig. 3a. The corresponding Vmax, kcat, and KM values for
each of the assemblies and controls were also estimated from
these data (Fig. 3b–d). Given the large concentration diﬀerence
between AuNP conjugates and substrate concentration, we
note that in principle the experimental format meets standard
Michaelis–Menten and Briggs–Haldane assumptions.51
The ratios of PTE3–AuNP utilized here were chosen so as to
approach maximum packing for the smaller AuNP and then
subsaturation for the larger materials. As expected, increasing
PTE3 concentration, both assembled on and oﬀ the AuNPs,
increased the apparent Vmax values, as more enzyme was able to
hydrolyze more substrate (Fig. 3b). For all the AuNP sizes and
ratios tested, PTE3 immobilization increased the observed Vmax.
At lower ratios of PTE3–AuNP, the relative improvement in Vmax
versus free enzyme was substantially higher displaying a nearly
17-fold increase at a 1 : 1 assembly ratio on the 20 nm AuNPs.
Increases of 6.5-fold and 10.5-fold were noted for the 10 and
5 nm particles at the same ratio. On the other hand, when the
ratio of PTE3–AuNP increased to 24, Vmax only increased by
approximately one third over the rate of free enzyme.
Comparing between the diﬀerent size AuNPs, PTE3 immo-
bilization on the 20 nm AuNPs demonstrated an average
enhancement (bioconjugate/free) of ∼1.7× and ∼1.1× higher
activity or turnover rate than the same PTE3–AuNP ratio of 10
and 5 nm, respectively. The catalytic rate (kcat) of PTE3 not
attached to AuNPs was averaged in order to get a truer catalytic
rate of free enzyme. As kcat (Vmax/[PTE3]) is directly correlated to
Vmax there is an identical increase in kcat for PTE3 attached to 5,
10, and 20 nm AuNP. As illustrated in Fig. 3c, kcat for PTE3–
AuNP is roughly constant, irrelevant of the concentration of the
enzyme for each sized AuNP with the average value of 11.0,
16.0, and 17.3 s−1 for 5, 10, and 20 nm, respectively, which is a
∼1.7× (20/5 nm) and ∼1.1× (20/10 nm) improvement. While
Vmax and kcat show a significant improvement for PTE3 immobi-
lized on the AuNP, the Michaelis constant KM, an indirect
measure of enzyme–substrate aﬃnity, remains similar to or
higher than the free enzyme, suggesting that PTE3 immobiliz-
ation on the AuNP tends to decrease enzyme–substrate aﬃnity.
However, it should be noted here that the measured KM values
for enzyme–NP conjugates are approximations at best since the
enzyme–substrate complex cannot be strictly modeled as freely
diﬀusing in solution. Moreover the Michaelis model overesti-
mates the number of diﬀusing multivalent NP conjugates as
well as underestimates the local concentration of enzyme in the
presence of the NP.19,20,25,34 We do note that similar increases
in KM values have been noted for attaching other enzymes to
the NPs.20 Finally, the catalytic eﬃciency of immobilized PTE3
(kcat/KM) is decreased when on the 5 nm AuNPs, ∼0.70×,
however, increased by ∼3.0× and ∼1.2× when immobilized on
the 10 and 20 nm AuNPs respectively.
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Interestingly, despite the smaller surface curvature of the
larger AuNPs, which may impede enzyme conformational
changes and increase the likelihood of detrimental enzyme
neighbor interactions, enzyme activity appears to be most
enhanced on the larger 20 nm AuNPs. This result is counter to
some of our previous observations where smaller NPs mani-
fested better enhancement of enzyme activity following attach-
ment.14,20 However, this previous work primarily utilized direct
enzyme attachment to the ZnS surface of CdSe/ZnS core/shell
QDs while in this work both the NP constituents and bioconju-
gation chemistry are distinct. This suggests that attachment
chemistry and NP material type plays a role in enhancing the
enzymatic behavior for distinct enzyme–NP constructs.
PTE3–AuNP activity characterization via fixed PTE3 concen-
tration method
Full enzyme progress curves (see ESI Fig. 3S, 4S, and 5S†)
were next acquired by fixed concentration of PTE3 while
increasing the bioconjugate molar ratio of PTE3–AuNP by
decreasing the AuNP concentration. This “fixed PTE3 concen-
tration method” was developed by fixing the PTE3 concen-
tration at 1.0 pM, while the concentration of the 5, 10, and
20 nm AuNPs were varied. This assay was performed to vali-
date and cross compare to the previous “fixed AuNP concen-
tration method” assay and subsequently the same enzyme
performance experiments were performed in this assay as
was performed in the previous. The resultant initial rate of
paraoxon hydrolysis by the PTE3–AuNP bioconjugates was
plotted against paraoxon substrate concentrations (Fig. 4a).
Again, when PTE3 is displayed on to the AuNP, most of the
bioconjugates have improved initial velocities and this is also
especially true for the bioconjugates at lower ratios of PTE3/
AuNP.
The corresponding Vmax, kcat, and KM values for each of the
assemblies and control were also estimated from the fixed
PTE3 concentration method assay and are compared as a
Fig. 3 Representative PTE3 enzymatic activity with ﬁxed AuNP concentration. Experiments conducted with constant AuNP concentration while
varying the PTE3 ratio displayed on the 5 nm, 10 nm, and 20 nm AuNPs. (a) Initial rates for each of the increasing PTE3 concentrations. Lines are ﬁts
to the data using the Michaelis–Menten formula while the symbols represent experimental data. Solid lines and squares are PTE3 attached to the
AuNPs while the dotted lines and triangles of the same color correspond to the identical concentration of PTE3 alone. Comparison of the (b) Vmax (c)
kcat and (d) KM values derived from the data (a) across all enzymes ratios. Blue bars represent PTE3 attached to AuNPs and red bars represent equi-
valent PTE3 free in solution. Error bars are the standard error from estimating the indicated values using repeated data.
Analyst Paper
This journal is © The Royal Society of Chemistry 2017 Analyst, 2017, 142, 3261–3271 | 3267
Pu
bl
ish
ed
 o
n 
26
 Ju
ne
 2
01
7.
 D
ow
nl
oa
de
d 
by
 Io
w
a S
ta
te
 U
ni
ve
rs
ity
 o
n 
15
/0
3/
20
18
 1
6:
40
:5
6.
 
View Article Online
function of ratio in Fig. 4b–d. Fig. 4b highlights the enhance-
ments in PTE3 Vmax that were observed. In almost every case the
incorporation of AuNPs increases Vmax, with higher enhanced
activity at lower ratios (1 : 1) and a slight decrease in activity at
high ratios (1 : 32), 2.3× and 0.75× respectively for 20 nm AuNP.
The same trends noted for Vmax values on the AuNP are also
observed in the derived kcat values, Fig. 4c. Although signifi-
cantly higher in value than the free enzyme control, kcat
appears to decrease as the ratio of PTE3–AuNP is increased.
There is also an increase in relative kcat as the AuNP increases
in size from 5, 10 and 20 nm. Similar to results found in the
fixed AuNP concentration method, KM maintains a fairly con-
sistent value for PTE3 immobilized onto the 5 and 10 nm
AuNPs but increases (enzyme aﬃnity worsens) for various
PTE3 concentrations on the 20 nm AuNPs. Resultant enzyme
eﬃciency (kcat/KM) calculations show an increase (5.0×) for the
5 nm AuNPs but a decrease on the 10 and 20 nm AuNP (0.68×
and 0.67× respectively).
Conclusions
In this work, we demonstrated that PTE3 enzymatic activity can
be significantly enhanced when immobilized onto AuNPs.
Results demonstrated Vmax could be enhanced nearly 17-fold
by immobilization on the 20 nm AuNP at low concentrations
of PTE3 (5 pM) and low ratio of PTE3–AuNP (1 : 1). These
results corroborate and exceed our previous results where PTE3
performance was enhanced when attached to multiple sized
QDs—upwards of four-fold improvement in kcat for PTE3
bound to 525 nm QDs versus free floating in solution.23 Other
researchers have explored the enhanced activity of enzymes
immobilized to AuNPs and have observed similar results. For
example, glucose oxidase immobilized on a 5 nm AuNPs dis-
played increases an order of magnitude higher Vmax – 1.42
µMmin−1 mg−1 immobilized on AuNP versus 0.25 µMmin−1 mg−1
for free glucose oxidase.38 Enhancement of other enzymes
such as glycosylated beta-galactosidase, which is commonly
Fig. 4 Representative PTE3 enzymatic activity with ﬁxed enzyme concentrations. Experiment conducted with constant PTE3 concentration while
varying the AuNP to PTE3 ratio for the 5 nm, 10 nm, 20 nm AuNPs. (a) Initial rates with constant PTE3 concentration as AuNP concentration
decreased. Lines are ﬁts to the data using the Michaelis–Menten formula while the symbols represent experimental data. Solid lines and squares are
PTE3 attached to the AuNPs while the dotted line and black triangles correspond to the identical concentration of PTE3 alone. Comparison of the (b)
Vmax (c) kcat and (d) KM values derived from the data in (a) across all the various ratios of enzymes used. Blue bars represent PTE3 attached to AuNPs
and red bars represent equivalent PTE3 free in solution. The error bars are the standard error from estimating the indicated values using repeated
data.
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used in lactose sensing, yielded over 10-fold increase in Vmax
(soluble enzyme 0.58 µmol min−1 mL−1 and immobilized on
AuNP 6.18 µmol min−1 mL−1).52
The number of PTE3 attached to the AuNP aﬀects the
observed activity of the enzyme as loading more PTE3 onto the
AuNP decreases the relative magnitude of the enhancement.
For example, PTE3 displayed a significantly higher catalytic
rate when immobilized at a 1 : 1 ratio of PTE3/AuNP, but then
showed a distinct decrease until the final 32 : 1 ratio (Fig. 4).
PTE3 enzyme immobilized on the larger 20 nm also displayed
the most significant increase in catalytic activity (kcat) values
with a ∼1.7× and ∼1.1× increase as compared to the same molar
ratio of enzyme immobilized on the 5 and 10 nm diameter
AuNP, respectively. The origins of these patterns are not easily
dissected out of the current data. As mentioned, the observation
of the largest enhancement in enzyme performance is noted
where the lowest molar ratios of PTE3 are immobilized on the
NPs—a behavior which mimics our previous reports on
improving PTE3 performance via immobilization on QDs.
14
Researchers postulate that the immobilization of enzymes in
lower density on NPs limits enzyme-to-enzyme neighbor inter-
actions and hence increases the likelihood of proper enzyme
conformation and subsequently higher enzyme activity or
more specifically increases in the rate of enzyme–substrate to
product conversion (k2).
20,24,44 However, our results also demon-
strate that PTE3 activity is higher on larger sized NPs (i.e., 20 nm
vs. 10 nm and 5 nm) which we previously postulated may
arise in part to the high localized density of PTE3 on the larger
NPs and overall increases in avidity of the enzyme–NP
bioconjugate.20
We do note a subtle but rather interesting discrepancy
between the two experimental formats utilized here. In the
first fixed AuNP concentration format, enzyme eﬃciency
(kcat/KM) decreased on the 5 nm AuNPs and increased when
the enzyme was immobilized on the larger NP materials. In
the second fixed enzyme format, the converse of this pattern is
observed. The origin of this pattern is not yet understood;
however, we hypothesize that it is associated with enzyme
packing and fitting on the NPs which could be far more con-
strained for smaller materials in the former experimental
format. Moreover, investigation of beta-galactosidase activity
when assembled on QDs also suggests the possibility of sub-
strate accumulation or sequestration in the NP interface,53 and
this, too, would be constrained or limiting for smaller
materials in the first experimental format by the increasing
amount of enzyme present. Lastly, it is again worth pointing
out the complexities of this interfacial environment and how
much still remains unknown about it. Clearly, it is not unrea-
sonable that subtle changes in experimental formats such as
variations in surface chemistry; enzyme position/orientation
and concentration; and substrate-to-NP attraction/diﬀusion
rates could give rise to changes in the enzyme–NP structure
and eﬃciency in which, in turn, changes the observed
activity.54
Clearly, far more work will be needed to elucidate the
underlying mechanism(s) and nuances that give rise to the
enhancement of enzymatic activity at a NP interface. These
include surveying a far larger size range of NP materials, a
range of NP surface chemistries, diﬀerent types of enzymes
and assays, and diﬀerent types of NP bioconjugation chem-
istries. What these types of studies will ultimately provide, is
insight into the nature of the NP–enzyme interface and how
this environment gives rise to enzymatic enhancement.
Critically, the nanoscale interfacial environment, including the
substrate and water boundary layers and gradients, immedi-
ately surrounding the enzyme–NP bioconjugate are postulated
phenomena that gives rise to such enzymatic enhancement.23
Unfortunately, there are almost no metrologies currently avail-
able to probe and characterize this nanoscale interfacial
environment,55 leaving the systematic and parametric func-
tional assays suggested above as the more realistic but still
indirect way forward.
Finally, the lower cost, facile fabrication protocol, and envir-
onmentally benign nature of AuNPs make them well suited as
a scaﬀold that hosts and augments enzymes for rapid in-field
OP sensors along with giving them excellent potential for
incorporation into protective materials. A simple in-field OP
sensor based on the PTE3–AuNP could be fabricated into a
florescence sensor utilizing a smartphone in a single step
readout.56 Similar photoluminescence sensors have been
shown for point-of-care measurements of hydrolase activity in
serum and whole blood using semiconductor QD FRET-based
detection.7 Furthermore, this work adds to the ever growing
body of NP–enzyme bioconjugates and suggests the appli-
cation of NP–enzyme conjugates for medical, research, indus-
trial and commercial utility which would certainly benefit
from enhanced and accelerated enzymatic activity.25,57,58 Such
enzyme–AuNP bioconjugates, and especially the phenomena
that they exploit, could have a significantly broad impact on a
variety of fields beyond biosensing to include environmental
remediation, synthetic biology and even batch chemical
processing.59
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